Federal contractors / CAREDX, INC.

IDV vehicle

36C24922D0027

GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
Office249-NETWORK CONTRACT OFFICE 9 (36C249)
NAICS541380 — Testing Laboratories and Services
PSCQ301 — Reference Laboratory Testing
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$2.7M
Start dateSep 23, 2022
Current end dateNot available
Potential end dateNot available
Latest award activityAug 19, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 19, 2026P00008$0IMPLEMENTING EO 14398 DEI DISCRIMINATION
Jul 13, 2026P00007$0GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)
Jul 22, 2025P00006$0GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)
Jul 8, 2025P00005$0GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)
Aug 12, 2024P00004$0GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)
Sep 18, 2023P00003$0GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)
Sep 13, 2023P00002$0GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)
Mar 20, 2023P00001$0GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)
Sep 22, 20220$0GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.